PPA
CPRX

Parametric Portfolio Associates’s Catalyst Pharmaceutical CPRX Stock Holding History

Parametric Portfolio Associates’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.83M Buy
341,584
+175,361
+105% +$1.24M ﹤0.01% 2227
2021
Q4 		$1.13M Sell
166,223
-2,175
-1% -$14.3K ﹤0.01% 2730
2021
Q3 		$893K Buy
168,398
+2,676
+2% +$14.6K ﹤0.01% 2846
2021
Q2 		$953K Sell
165,722
-41,533
-20% -$214K ﹤0.01% 2792
2021
Q1 		$955K Buy
207,255
+87,726
+73% +$349K ﹤0.01% 3182
2020
Q4 		$399K Buy
119,529
+2,344
+2% +$7.88K ﹤0.01% 3475
2020
Q3 		$348K Buy
117,185
+29,487
+34% +$115K ﹤0.01% 3428
2020
Q2 		$405K Buy
87,698
+38,345
+78% +$172K ﹤0.01% 3356
2020
Q1 		$190K Sell
49,353
-12,655
-20% -$51.9K ﹤0.01% 3571
2019
Q4 		$233K Buy
62,008
+49,429
+393% +$231K ﹤0.01% 3680
2019
Q3 		$67K Buy
+12,579
New +$67K ﹤0.01% 3881
2019
Q2 		– Sell
-186,708
Closed -$952K – 3961
2019
Q1 		$952K Buy
+186,708
New +$549K ﹤0.01% 3058
2018
Q1 		– Sell
-261,325
Closed -$1.02M – 3937
2017
Q4 		$1.02M Buy
+261,325
New +$863K ﹤0.01% 3012

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Parametric Portfolio Associates's CPRX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Catalyst Pharmaceutical (CPRX) stake by 105% in Q1 2022, buying an estimated $1.24M and bringing the position to 341,584 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Parametric Portfolio Associates first reported a position in CPRX in Q4 2017 and has held it in 13 quarters since. 187 funds tracked by Wall St. Rank hold CPRX as of Q1 2022.

  • Parametric Portfolio Associates held 341,584 shares of Catalyst Pharmaceutical worth $2.83M as of Q1 2022.
  • Parametric Portfolio Associates bought 175,361 Catalyst Pharmaceutical shares in Q1 2022, an estimated $1.24M.
  • Catalyst Pharmaceutical made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2227 holding.
  • Parametric Portfolio Associates first reported a position in Catalyst Pharmaceutical in Q4 2017 and has held it in 13 quarters since.
  • 187 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.